Table 2.
Demographic and Clinical Characteristics of Participants
| Total N = 43 Frequency (%) | Intervention N = 22 Frequency (%) | Control N = 21 Frequency (%) | p Value | |
|---|---|---|---|---|
| ATN site | 0.974 | |||
| Tampa | 14 (32.6) | 7 (31.8) | 7 (33.3) | |
| Chicago | 13 (30.2) | 7 (31.8) | 6 (28.6) | |
| Baltimore | 16 (37.2) | 8 (36.4) | 8 (38.1) | |
| Age | ||||
| 16–18 years | 14 (32.6) | 5 (22.7) | 9 (42.9) | 0.159 |
| 19–24 years | 29 (67.4) | 17 (77.3) | 12 (57.1) | |
| Median (IQR) | 21 (17–22) | 21 (19–23) | 20 (17–22) | 0.184 |
| Race | 0.457 | |||
| African-American/non-Hispanic | 35 (81.4) | 19 (86.4) | 16 (76.2) | |
| White/Hispanic/other race/ethnicity | 8 (18.6) | 3 (13.6) | 5 (23.8) | |
| Highest level of education completed | 0.287 | |||
| Less than high school | 21 (48.8) | 9 (40.9) | 12 (57.1) | |
| High school/GED/college/technical | 22 (51.2) | 13 (59.1) | 9 (42.9) | |
| Currently in school | 0.835 | |||
| No | 15 (34.9) | 8 (36.4) | 7 (33.3) | |
| Yes or graduated | 28 (65.1) | 14 (63.6) | 14 (66.7) | |
| Sexual orientation | 0.281 | |||
| Straight | 34 (79.1) | 19 (86.4) | 15 (71.4) | |
| Bisexual | 9 (20.9) | 3 (13.6) | 6 (28.6) | |
| Time since diagnosis ≤12 months | 5 (11.6) | 2 (9.1) | 3 (14.3) | 0.664 |
| Taking ARV medications | 25 (58.1) | 13 (59.1) | 12 (57.1) | 0.897 |
| Ever pregnant | 26 (60.5) | 11(50.0) | 6 (28.6) | 0.151 |
| Not in contact with father | 26 (61.9) | 15 (68.2) | 11 (55.0) | 0.380 |
| Not in contact with mother | 14 (33.3) | 8 (36.4) | 6 (30.0) | 0.662 |
| No. male sexual partners past 3 months | 0.094 | |||
| 0 | 10 (23.8) | 2 (9.5) | 8 (38.1) | |
| 1 | 17 (40.5) | 10 (47.6) | 7 (33.3) | |
| 2 or more | 15 (35.7) | 9 (42.9) | 6 (28.6) | |
| No. partners known to be HIV positivea | 0.999 | |||
| 0 | 27/31 (87.1) | 16/18 (88.9) | 11/13 (84.6) | |
| 1–2 | 4/31 (12.9) | 2/18 (11.1) | 2/13 (15.4) | |
| No. partners known to be HIV negative or unknowna | 0.189 | |||
| 0 | 7/30 (23.3) | 6/17 (35.3) | 1/13 (7.7) | |
| 1 | 13/30 (43.3) | 7/17 (41.2) | 6/13 (46.2) | |
| 2 or more | 10/30 (33.3) | 4/17 (23.5) | 6/13 (46.2) | |
| Any UVI in past 3 monthsa | 14/30 (46.7) | 7/17 (41.2) | 7/13 (53.9) | 0.713 |
| With HIV+ partner | 3/31 (9.7) | 2/18 (11.1) | 1 (7.7) | 0.999 |
| With HIV- or unknown partner | 11/29 (37.9) | 5/16 (31.3) | 6/13 (46.2) | 0.466 |
| Any UAI in past 3 monthsa | 3/29 (10.3) | 1/16 (6.3) | 2/13 (15.4) | 0.573 |
| With HIV+ partner | 1/30 (3.3) | 1/17 (5.9) | 0/13 (0.0) | 0.999 |
| With HIV- or unknown partner | 2/29 (6.9) | 0/16 (0.0) | 2/13 (15.4) | 0.192 |
a
Among sexually active participants (N = 32); denominators vary due to missing data.